Parameswaran N Hari


Ontology type: schema:Person     


Person Info

NAME

Parameswaran N

SURNAME

Hari

Publications in SciGraph latest 50 shown

  • 2022-10-26 Exploring health behaviors and the feasibility of a lifestyle intervention for patients with multiple myeloma in SUPPORTIVE CARE IN CANCER
  • 2022-07-06 FOXM1 regulates glycolysis and energy production in multiple myeloma in ONCOGENE
  • 2022-05-25 Socioeconomic disadvantage contributes to ethnic disparities in multiple myeloma survival: a matched cohort study in BLOOD CANCER JOURNAL
  • 2022-05-12 Patient-reported outcomes and neurotoxicity markers in patients treated with bispecific LV20.19 CAR T cell therapy in COMMUNICATIONS MEDICINE
  • 2022-04-18 Safety analysis of patients who received ruxolitinib for steroid-refractory acute or chronic graft-versus-host disease in an expanded access program in BONE MARROW TRANSPLANTATION
  • 2022-04-01 Patient perspectives on symptoms, health-related quality of life, and treatment experience associated with relapsed/refractory multiple myeloma in SUPPORTIVE CARE IN CANCER
  • 2022-02-24 Black patients with multiple myeloma have better survival than white patients when treated equally: a matched cohort study in BLOOD CANCER JOURNAL
  • 2022-02-10 Mass-Fix better predicts for PFS and OS than standard methods among multiple myeloma patients participating on the STAMINA trial (BMT CTN 0702 /07LT) in BLOOD CANCER JOURNAL
  • 2021-12-07 WDR26 and MTF2 are therapeutic targets in multiple myeloma in JOURNAL OF HEMATOLOGY & ONCOLOGY
  • 2021-11-20 Treatment outcomes of triple class refractory multiple myeloma: a benchmark for new therapies in LEUKEMIA
  • 2021-06-05 Correction to: Hematopoietic cell transplantation utilization and outcomes for primary plasma cell leukemia in the current era in LEUKEMIA
  • 2021-03-29 Correction to: Hematopoietic cell transplantation utilization and outcomes for primary plasma cell leukemia in the current era in LEUKEMIA
  • 2021-03-25 Unrelated Donor Allogeneic Transplant in CONTEMPORARY BONE MARROW TRANSPLANTATION
  • 2021-03-25 Cellular Therapy in CONTEMPORARY BONE MARROW TRANSPLANTATION
  • 2021-01-14 Engraftment in BLOOD AND MARROW TRANSPLANT HANDBOOK
  • 2021-01-14 Graft Failure in BLOOD AND MARROW TRANSPLANT HANDBOOK
  • 2020-12-08 Unrelated Donor Allogeneic Transplant in CONTEMPORARY BONE MARROW TRANSPLANTATION
  • 2020-10-05 Bispecific anti-CD20, anti-CD19 CAR T cells for relapsed B cell malignancies: a phase 1 dose escalation and expansion trial in NATURE MEDICINE
  • 2020-08-11 International harmonization in performing and reporting minimal residual disease assessment in multiple myeloma trials in LEUKEMIA
  • 2020-08-07 Chimeric antigen receptor T cell therapy in multiple myeloma: promise and challenges in BONE MARROW TRANSPLANTATION
  • 2020-08-04 Salvage second transplantation in relapsed multiple myeloma in LEUKEMIA
  • 2020-07-30 Prevalence and significance of sarcopenia in multiple myeloma patients undergoing autologous hematopoietic cell transplantation in BONE MARROW TRANSPLANTATION
  • 2020-06-01 Multiple myeloma and COVID-19 in LEUKEMIA
  • 2020-05-14 A dose-finding Phase 2 study of single agent isatuximab (anti-CD38 mAb) in relapsed/refractory multiple myeloma in LEUKEMIA
  • 2020-05-11 Biomarkers in individualized management of chimeric antigen receptor T cell therapy in BIOMARKER RESEARCH
  • 2020-04-20 Hematopoietic cell transplantation utilization and outcomes for primary plasma cell leukemia in the current era in LEUKEMIA
  • 2020-04-14 Long-term survival of 1338 MM patients treated with tandem autologous vs. autologous-allogeneic transplantation in BONE MARROW TRANSPLANTATION
  • 2020-04-02 Cellular Therapy in CONTEMPORARY BONE MARROW TRANSPLANTATION
  • 2019-11-19 Gut microbiome and CAR-T therapy in EXPERIMENTAL HEMATOLOGY & ONCOLOGY
  • 2019-09-03 Rituximab-based allogeneic transplant for chronic lymphocytic leukemia with comparison to historical experience in BONE MARROW TRANSPLANTATION
  • 2019-08-16 Oprozomib in patients with newly diagnosed multiple myeloma in BLOOD CANCER JOURNAL
  • 2019-07-29 Phase I/II trial of bendamustine, ixazomib, and dexamethasone in relapsed/refractory multiple myeloma in BLOOD CANCER JOURNAL
  • 2019-03-11 Outcomes of patients with multiple myeloma refractory to CD38-targeted monoclonal antibody therapy in LEUKEMIA
  • 2019-01-29 Virus detection in the cerebrospinal fluid of hematopoietic stem cell transplant recipients is associated with poor patient outcomes: a CIBMTR contemporary longitudinal study in BONE MARROW TRANSPLANTATION
  • 2019-01-29 Ixazomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma: long-term follow-up including ixazomib maintenance in LEUKEMIA
  • 2018-06-15 Final outcomes of escalated melphalan 280 mg/m2 with amifostine cytoprotection followed autologous hematopoietic stem cell transplantation for multiple myeloma: high CR and VGPR rates do not translate into improved survival in BONE MARROW TRANSPLANTATION
  • 2018-05-24 Repurposing existing medications as cancer therapy: design and feasibility of a randomized pilot investigating propranolol administration in patients receiving hematopoietic cell transplantation in BMC CANCER
  • 2018-04-20 Use of propylene glycol-free melphalan conditioning in light-chain amyloidosis patients undergoing autologous hematopoietic cell transplantation is well tolerated and effective in BONE MARROW TRANSPLANTATION
  • 2018-03-12 Association between response kinetics and outcomes in relapsed/refractory multiple myeloma: analysis from TOURMALINE-MM1 in LEUKEMIA
  • 2017-11-16 Early relapse after autologous hematopoietic cell transplantation remains a poor prognostic factor in multiple myeloma but outcomes have improved over time in LEUKEMIA
  • 2017-11-06 Haploidentical Hematopoietic Cell Transplantation in Lymphomas in HAPLOIDENTICAL TRANSPLANTATION
  • 2017-09-18 Autologous hematopoietic cell transplantation for multiple myeloma patients with renal insufficiency: a center for international blood and marrow transplant research analysis in BONE MARROW TRANSPLANTATION
  • 2017-06-13 Trends in pre- and post-transplant therapies with first autologous hematopoietic cell transplantation among patients with multiple myeloma in the United States, 2004–2014 in LEUKEMIA
  • 2017-04-25 Efficacy and safety of carfilzomib regimens in multiple myeloma patients relapsing after autologous stem cell transplant: ASPIRE and ENDEAVOR outcomes in LEUKEMIA
  • 2016-09-05 Impact of haploidentical hematopoietic cell transplantation conditioning intensity on the incidence and severity of post-transplantation viral infections in BONE MARROW TRANSPLANTATION
  • 2016-08-01 Marrow grafts from HLA-identical siblings for severe aplastic anemia: does limiting the number of transplanted marrow cells reduce the risk of chronic GvHD? in BONE MARROW TRANSPLANTATION
  • 2016-08-01 Salvage haploidentical hematopoietic cell transplantation for graft rejection following a prior haploidentical allograft in BONE MARROW TRANSPLANTATION
  • 2016-07-27 HLA polymorphism and risk of multiple myeloma in LEUKEMIA
  • 2016-07-18 A multicenter trial of myeloablative clofarabine and busulfan conditioning for relapsed or primary induction failure AML not in remission at the time of allogeneic hematopoietic stem cell transplantation in BONE MARROW TRANSPLANTATION
  • 2016-01-04 Allogeneic stem cell transplantation for multiple myeloma: is there a future? in BONE MARROW TRANSPLANTATION
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "http://www.grid.ac/institutes/grid.30760.32", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.418562.c", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.410425.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.477947.e", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.39382.33", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.412315.0", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.170205.1", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.268154.c", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.415719.f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.59734.3c", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.414054.0", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.415792.c", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.415100.1", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.223827.e", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.416818.2", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.412578.d", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.25073.33", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.476875.f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.7445.2", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.65499.37", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.38142.3c", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.240145.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.8993.b", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.414660.1", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.63368.38", 
            "type": "Organization"
          }
        ], 
        "familyName": "Hari", 
        "givenName": "Parameswaran N", 
        "id": "sg:person.01170403141.13", 
        "identifier": [
          {
            "name": "orcid_id", 
            "type": "PropertyValue", 
            "value": "0000-0002-8800-297X"
          }
        ], 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01170403141.13", 
          "https://orcid.org/0000-0002-8800-297X"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2022-11-24T21:36", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221124/entities/gbq_results/person/person_663.jsonl", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.01170403141.13'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.01170403141.13'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.01170403141.13'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.01170403141.13'


     

    This table displays all metadata directly associated to this object as RDF triples.

    69 TRIPLES      11 PREDICATES      37 URIs      8 LITERALS      3 BLANK NODES

    Subject Predicate Object
    1 sg:person.01170403141.13 schema:affiliation N6810ecb0ce55412cb552104faa614ffa
    2 grid-institutes:grid.170205.1
    3 grid-institutes:grid.223827.e
    4 grid-institutes:grid.240145.6
    5 grid-institutes:grid.25073.33
    6 grid-institutes:grid.268154.c
    7 grid-institutes:grid.38142.3c
    8 grid-institutes:grid.39382.33
    9 grid-institutes:grid.410425.6
    10 grid-institutes:grid.412315.0
    11 grid-institutes:grid.412578.d
    12 grid-institutes:grid.414054.0
    13 grid-institutes:grid.414660.1
    14 grid-institutes:grid.415100.1
    15 grid-institutes:grid.415719.f
    16 grid-institutes:grid.415792.c
    17 grid-institutes:grid.416818.2
    18 grid-institutes:grid.418562.c
    19 grid-institutes:grid.476875.f
    20 grid-institutes:grid.477947.e
    21 grid-institutes:grid.59734.3c
    22 grid-institutes:grid.63368.38
    23 grid-institutes:grid.65499.37
    24 grid-institutes:grid.7445.2
    25 grid-institutes:grid.8993.b
    26 schema:familyName Hari
    27 schema:givenName Parameswaran N
    28 schema:identifier Nf0805bc713834f308e19c44414b04ad3
    29 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01170403141.13
    30 https://orcid.org/0000-0002-8800-297X
    31 schema:sdDatePublished 2022-11-24T21:36
    32 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    33 schema:sdPublisher N9cc006a76b854fb99137e9d22d837e1c
    34 sgo:license sg:explorer/license/
    35 sgo:sdDataset persons
    36 rdf:type schema:Person
    37 N6810ecb0ce55412cb552104faa614ffa schema:affiliation grid-institutes:grid.30760.32
    38 sgo:isCurrent true
    39 rdf:type schema:OrganizationRole
    40 N9cc006a76b854fb99137e9d22d837e1c schema:name Springer Nature - SN SciGraph project
    41 rdf:type schema:Organization
    42 Nf0805bc713834f308e19c44414b04ad3 schema:name orcid_id
    43 schema:value 0000-0002-8800-297X
    44 rdf:type schema:PropertyValue
    45 grid-institutes:grid.170205.1 schema:Organization
    46 grid-institutes:grid.223827.e schema:Organization
    47 grid-institutes:grid.240145.6 schema:Organization
    48 grid-institutes:grid.25073.33 schema:Organization
    49 grid-institutes:grid.268154.c schema:Organization
    50 grid-institutes:grid.30760.32 schema:Organization
    51 grid-institutes:grid.38142.3c schema:Organization
    52 grid-institutes:grid.39382.33 schema:Organization
    53 grid-institutes:grid.410425.6 schema:Organization
    54 grid-institutes:grid.412315.0 schema:Organization
    55 grid-institutes:grid.412578.d schema:Organization
    56 grid-institutes:grid.414054.0 schema:Organization
    57 grid-institutes:grid.414660.1 schema:Organization
    58 grid-institutes:grid.415100.1 schema:Organization
    59 grid-institutes:grid.415719.f schema:Organization
    60 grid-institutes:grid.415792.c schema:Organization
    61 grid-institutes:grid.416818.2 schema:Organization
    62 grid-institutes:grid.418562.c schema:Organization
    63 grid-institutes:grid.476875.f schema:Organization
    64 grid-institutes:grid.477947.e schema:Organization
    65 grid-institutes:grid.59734.3c schema:Organization
    66 grid-institutes:grid.63368.38 schema:Organization
    67 grid-institutes:grid.65499.37 schema:Organization
    68 grid-institutes:grid.7445.2 schema:Organization
    69 grid-institutes:grid.8993.b schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...